Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael P Kane

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Postgraduate Medicine|June 29, 2017
Combination SGLT2 inhibitor and GLP-1 receptor agonist therapy: a complementary approach to the treatment of type 2 diabetesRobert S Busch, Michael P Kane
Journal of Pharmacy Practice|July 5, 2019
Programmed Cell Death-1 Monoclonal Antibody Therapy and Type 1 Diabetes Mellitus: A Review of the LiteratureKyle A Farina, Michael P Kane
The Diabetes Educator|April 8, 2011
Primer on pramlintide, an amylin analogAndrea N Traina, Michael P Kane
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Analysis of cost and utilization of health care services before and after initiation of insulin therapy in patients with type 2 diabetes mellitusMichael S Rosenblum, Michael P Kane
The Annals of Pharmacotherapy|March 16, 2006
Drug-induced thyrotoxic periodic paralysisMichael P Kane, Robert S Busch
Clinical Diabetes : a Publication of the American Diabetes Association|January 17, 2024
Current Understanding of Sodium N-(8-[2-Hydroxylbenzoyl] Amino) Caprylate (SNAC) as an Absorption Enhancer: The Oral Semaglutide ExperienceCarolina Solis-Herrera, Michael P Kane, Curtis Triplitt
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2004
Epothilones: mechanism of action and biologic activitySusan Goodin, Michael P Kane, Eric H Rubin
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 19, 2003
Pharmacist-run teriparatide clinicJeffrey Stroup, Michael P Kane, Robert S Busch
Pharmacotherapy|July 30, 2003
Angiotensin-converting enzyme inhibitors and type 2 diabetic nephropathy: a meta-analysisRobert A Hamilton, Michael P Kane, Jason Demers
Case Reports in Pediatrics|November 14, 2013
Off-label use of liraglutide in the management of a pediatric patient with type 2 diabetes mellitusSara J Micale, Michael P Kane, Eileen Hogan
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Postgraduate Medicine|June 29, 2017
Combination SGLT2 inhibitor and GLP-1 receptor agonist therapy: a complementary approach to the treatment of type 2 diabetesRobert S Busch, Michael P Kane
Journal of Pharmacy Practice|July 5, 2019
Programmed Cell Death-1 Monoclonal Antibody Therapy and Type 1 Diabetes Mellitus: A Review of the LiteratureKyle A Farina, Michael P Kane
The Diabetes Educator|April 8, 2011
Primer on pramlintide, an amylin analogAndrea N Traina, Michael P Kane
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Analysis of cost and utilization of health care services before and after initiation of insulin therapy in patients with type 2 diabetes mellitusMichael S Rosenblum, Michael P Kane
The Annals of Pharmacotherapy|March 16, 2006
Drug-induced thyrotoxic periodic paralysisMichael P Kane, Robert S Busch
Clinical Diabetes : a Publication of the American Diabetes Association|January 17, 2024
Current Understanding of Sodium N-(8-[2-Hydroxylbenzoyl] Amino) Caprylate (SNAC) as an Absorption Enhancer: The Oral Semaglutide ExperienceCarolina Solis-Herrera, Michael P Kane, Curtis Triplitt
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2004
Epothilones: mechanism of action and biologic activitySusan Goodin, Michael P Kane, Eric H Rubin
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 19, 2003
Pharmacist-run teriparatide clinicJeffrey Stroup, Michael P Kane, Robert S Busch
Pharmacotherapy|July 30, 2003
Angiotensin-converting enzyme inhibitors and type 2 diabetic nephropathy: a meta-analysisRobert A Hamilton, Michael P Kane, Jason Demers
Case Reports in Pediatrics|November 14, 2013
Off-label use of liraglutide in the management of a pediatric patient with type 2 diabetes mellitusSara J Micale, Michael P Kane, Eileen Hogan
Pageof 5